Activity Preview


Addressing Barriers to Clozapine Underutilization

Activity Type:

  • Webinar

Release Date: 4/1/2019

Expiration Date: 5/25/2019

  • AMA PRA Category 1: 1
  • CNE: 1
  • Participation: 1


Event Details

The live presentation will take place on April 25, 2019, 3:00-4:00pm ET.

Advance registration is encouraged. Registrants will receive an event reminder by email one day prior to the webinar.


Clozapine is a medication that exhibits unique efficacy and effective for those with serious mental illness. However, the risks of using clozapine, the monitoring required for its use, issues facing prescribers who may wish to employ it, and a variety of administrative burdens have all proved to be barriers to its more widespread use. This presentation will discuss the barriers to the use of clozapine and recommendations of a national workgroup seeking to overcome these barriers.


FREE - $0

Funding for this initiative was made possible (in part) by Grant No. 1H79SM080818-01 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. 

Learning Objectives

  • Discuss the utility of clozapine in the treatment of serious mental disorders
  • List barriers to the use of clozapine and discuss collaborative strategies to increase access and improve its utilization
  • Explain new guidelines and requirements for clozapine monitoring in the US including the impact and recognition of Benign Ethnic Neutropenia

Target Audience

Nurse/Nurse Practitioner; Pharmacist; Psychiatrist; Physician (non-psychiatrist); Physician Assistant; Social Worker

Instructional Level


Estimated Time to Complete

Estimated Duration: 1.0 hours 
Program Start Date: April 25, 2019 
Program End Date: April 25, 2019 

How to Earn Credit

Participants who wish to earn AMA PRA Category 1 Credit™, ANCC pharmacology contact hours, or a certificate of participation may do so by attending the live presentation and completing the evaluation. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians), CNE certificate (nursing), or certificate of participation (non-physicians) showing the event date and hours earned.

Continuing Education Credit


The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The APA designates this live event for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses/Nurse Practitioners

The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Faculty and Planner Disclosures


  • Deanna Kelly, PharmD, BCPP, University of Maryland, School of Medicine. Disclosure: Consultant- HLS Therapeutics, Alkermes, Lundbeck, Saladax. 
  • Raymond Love, PharmD, BCPP, FASHP, University of Maryland, School of Pharmacy. Disclosure: Consultant- Maryland Medicaid Pharmacy Program; Grant/Research- National Institutes of Health, Maryland Department of Health; Honoraria - American Psychiatric Association, Nevada Psychiatric Association, American Pharmacists Association, and the National Alliance of State Pharmacy Associations. 


  • Tristan Gorrindo, MD, American Psychiatric Association. Reports no financial relationships with commercial interests.
  • Donna Rolin, PhD, APRN. University of Texas at Austin. Reports no financial relationships with commercial interests. 
  • Alexander Young, MD, UCLA Department of Psychiatry and Biobehavioral Sciences. Reports no financial relationships with commercial interests.   
  • Teri Brister, PhD, LPC, National Alliance on Mental Illness. Reports no financial relationships with commercial interests.

Accessibility for Participants with Disabilities

The American Psychiatric Association is committed to ensuring accessibility of its website to people with disabilities.  Please contact the American Psychiatric Association at 202-559-3900, if you require assistance seven (7) days prior to the start of a live webinar.

Hardware/Software Requirements

We recommend that prior to the webinar, you check system requirements to ensure your device is compatible and rule out connectivity issuess.

This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This website requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration

  • Flash Player: Adobe Flash Player 10.3+ 
  • Browser: Firefox (latest version), Internet Explorer 8.0+, Safari 7.0+, Microsoft Edge (latest version) or Google Chrome (latest version)
  • Operating System: Windows XP+ or Mac OS X 10.4+ 
  • Internet Connection: 1 Mbps or higher

Minimum Requirements

  • Windows PC: 500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Macromedia Flash Player 10.3 or higher; Sound Card at least 16-bit; audio playback with speakers for programs with video content
  • Macintosh:Mac OS X 10.4+ or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit; audio playback with speakers for programs with video content

For assistance: Contact for questions about this course | Contact for technical assistance